Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases
Majority of Invasive Bladder Cancer Patients Do Not Receive Full Recommended Care
Pertuzumab Delays Progression In HER2-Positive Breast Cancer
Sentinel Lymph Node Excision Has No Impact on Survival
Increased Breast Density Can Lead to Higher Risk
Computer Interpretation Software Does Not Improve Detection
Bone Marrow Transplant Survival Has Doubled In Young Patients
Two Studies Demonstrate Molecule Blocking Cell Damage
Interim Analysis Suggests Paclical Can Reduce Blood Levels
Hormone Therapy Can Reduce Survival In Men With Heart Problems
Zometa Can Reduce Risk Of Skeletal-Related Events
Cell Phone Radiation Does Not Raise Child’s Risk of Tumors
Clinical Trials Approved by NCI CTEP Last Month
Trending Stories
- Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- Trump 2016: A look back at the 45th president’s impact on oncology
- Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Rooting out the “illegal and immoral discrimination” of DEI is the first order of business for Trump
